Related Experiment Video

Updated: Jun 4, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Management of hepatitis C virus genotype 4: recommendations of an international expert panel

Mahmoud A Khattab1, Peter Ferenci, Stephanos J Hadziyannis

  • 1Department of Internal Medicine, University of Minia, Egypt. mkhattabmed@hotmail.com

Journal of Hepatology
|February 15, 2011
PubMed

Insights

Hepatitis C Virus genotype 4 (HCV-4) is prevalent in Africa and the Middle East, causing significant liver disease. This review synthesizes current knowledge on HCV-4 epidemiology, clinical features, and treatment.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C Virus (HCV) exhibits genetic diversity with six major genotypes and numerous subtypes.
  • HCV genotypes differ in nucleotide sequence, geographic prevalence, and therapeutic response.
  • HCV genotypes 1, 2, and 3 are common in North America and Europe, while HCV genotype 4 (HCV-4) predominates in the Middle East and Africa.

Purpose of the Study:

  • To review and consolidate current knowledge on HCV-4.
  • To cover epidemiology, natural history, clinical and histological features, and treatment of HCV-4 infections.

Main Methods:

  • Expert panel review of existing literature.
  • Synthesis of data on HCV-4.

Main Results:

  • HCV-4 is responsible for over 80% of HCV infections in the Middle East and Africa.
  • HCV-4 is a significant cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions.
  • Despite causing approximately 20% of global chronic hepatitis C cases, HCV-4 has been under-researched.

Conclusions:

  • HCV-4 represents a substantial global health burden, particularly in specific geographic regions.
  • Further research is needed to fully understand and manage HCV-4 infections.
  • A comprehensive understanding of HCV-4 is crucial for effective clinical management and public health strategies.

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...